• 1. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

5-Azido-3-iodo-1H-indazole (CAS No. 876365-97-8): A Versatile Building Block in Medicinal Chemistry and Drug Discovery

5-Azido-3-iodo-1H-indazole (CAS No. 876365-97-8) is a highly functionalized heterocyclic compound that has gained significant attention in recent years due to its unique structural features and broad applicability in medicinal chemistry. This indazole derivative combines two highly reactive functional groups - an azido group and an iodo substituent - making it an exceptionally valuable intermediate for various chemical transformations, particularly in the synthesis of biologically active compounds.

The growing interest in 5-Azido-3-iodo-1H-indazole reflects current trends in pharmaceutical research, where scientists are increasingly focusing on click chemistry approaches for rapid compound library generation. The compound's azide functionality enables efficient Huisgen cycloaddition reactions with alkynes, while the iodo group offers opportunities for various cross-coupling reactions, making it a dual-purpose building block in drug discovery programs.

Recent studies highlight the importance of indazole scaffolds in developing kinase inhibitors, with several FDA-approved drugs featuring this core structure. The presence of both azido and iodo groups in 5-Azido-3-iodo-1H-indazole allows for strategic modifications that can lead to novel compounds with potential therapeutic applications. Researchers are particularly interested in how this compound can be used to create PROTACs (Proteolysis Targeting Chimeras), a hot topic in current drug discovery that addresses challenging protein targets.

From a synthetic chemistry perspective, 5-Azido-3-iodo-1H-indazole offers remarkable versatility. The iodo substituent at the 3-position undergoes efficient Sonogashira coupling, Suzuki-Miyaura coupling, and other palladium-catalyzed reactions, while the azido group at the 5-position participates in various click chemistry transformations. This dual reactivity makes the compound particularly valuable for creating diverse molecular architectures with potential biological activity.

The physicochemical properties of 5-Azido-3-iodo-1H-indazole contribute to its utility in drug discovery. With moderate lipophilicity and molecular weight, derivatives of this compound often exhibit favorable drug-like properties. The indazole core provides a rigid framework that can enhance binding affinity to biological targets, while the functional groups allow for strategic modifications to optimize pharmacokinetic parameters.

In the context of current pharmaceutical trends, 5-Azido-3-iodo-1H-indazole has become particularly relevant for the development of covalent inhibitors. The azido group can be reduced to an amine for subsequent derivatization, or used directly in bioorthogonal chemistry applications. Meanwhile, the iodo substituent can be employed in various cross-coupling reactions to rapidly generate diverse compound libraries for screening against emerging biological targets.

Recent publications have demonstrated the use of 5-Azido-3-iodo-1H-indazole in the synthesis of potential anticancer agents, particularly those targeting protein kinases. The compound's ability to serve as a precursor for various heterocyclic systems makes it valuable for exploring structure-activity relationships in medicinal chemistry programs. Its applications extend to materials science as well, where its unique structure contributes to the development of novel functional materials.

The stability and handling characteristics of 5-Azido-3-iodo-1H-indazole have been subjects of recent optimization efforts. While the azido group requires careful handling, modern synthetic protocols have established safe and efficient methods for its utilization. These advancements have increased the compound's accessibility to researchers working in various fields, from academic laboratories to industrial R&D facilities.

Looking forward, 5-Azido-3-iodo-1H-indazole is poised to play an increasingly important role in fragment-based drug discovery. Its relatively small size combined with multiple points for derivatization makes it an ideal starting point for growing molecular fragments into lead compounds. The current emphasis on targeted protein degradation strategies in drug discovery further enhances the value of this versatile building block.

In conclusion, 5-Azido-3-iodo-1H-indazole (CAS No. 876365-97-8) represents a powerful tool for modern medicinal chemists. Its unique combination of reactive functional groups on a privileged indazole scaffold enables diverse chemical transformations that are crucial for addressing current challenges in drug discovery. As research continues to explore new applications for this compound, its importance in the development of novel therapeutic agents and functional materials is expected to grow significantly.

• 885519-20-0(3-Iodo-1H-indazol-6-amine)
• 885521-28-8(3-Iodo-1H-indazol-4-amine)
• 876365-98-9(1H-INDAZOLE, 6-AZIDO-3-IODO-)
• 599183-36-5(3-Iodo-1H-indazol-5-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)